Delysid

E1020535

Delysid was the trade name under which the psychedelic drug LSD was originally marketed for psychiatric and experimental use in the mid-20th century.

All labels observed (1)

Label Occurrences
Delysid canonical 1

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf psychedelic drug ⓘ
trade name ⓘ
activeIngredient lysergic acid diethylamide ⓘ
brandStatus discontinued ⓘ
chemicalSubstance C20H25N3O ⓘ
countryOfOrigin Switzerland ⓘ
developedBy Sandoz Laboratories ⓘ
linked to: Sandoz
firstMarketedBy Sandoz ⓘ
formulation ampoules ⓘ
tablets ⓘ
hasEffect altered perception ⓘ
cognitive changes ⓘ
hallucinations ⓘ
mood changes ⓘ
historicalUsePeriod mid-20th century ⓘ
indicatedUse experimental psychiatry ⓘ
model psychosis induction ⓘ
psychotherapy adjunct ⓘ
introducedForUse clinical psychiatry ⓘ
experimental psychotherapy ⓘ
psychiatric research ⓘ
introducedInDecade 1940s ⓘ
isSameAs Sandoz LSD preparation ⓘ
linked to: Sandoz
legalStatus withdrawn from medical market ⓘ
manufacturer Sandoz Laboratories ⓘ
linked to: Sandoz
mechanismOfAction 5-HT2A receptor agonist ⓘ
pharmacologicalClass ergoline derivative ⓘ
serotonergic psychedelic ⓘ
regulatoryOutcome subject to international control under UN drug conventions ⓘ
relatedConcept hallucinogens ⓘ
psychedelic therapy ⓘ
psychotomimetic agents ⓘ
risk acute anxiety reactions ⓘ
precipitation of psychosis in vulnerable individuals ⓘ
psychological distress ⓘ
routeOfAdministration intramuscular injection ⓘ
intravenous injection ⓘ
oral ⓘ
tradeNameOf LSD ⓘ
lysergic acid diethylamide ⓘ
typicalDoseRange 25 micrograms to 100 micrograms ⓘ
usedAs tool for studying consciousness ⓘ
tool for studying schizophrenia ⓘ
usedBy clinical researchers ⓘ
psychiatrists ⓘ
psychotherapists ⓘ
withdrawnInDecade 1960s ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

LSD → wasMarketedAs → Delysid ⓘ